TONIALINI, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 452
EU - Europa 282
AS - Asia 145
AF - Africa 27
OC - Oceania 1
SA - Sud America 1
Totale 908
Nazione #
US - Stati Uniti d'America 449
GB - Regno Unito 67
SE - Svezia 67
VN - Vietnam 64
CN - Cina 46
IT - Italia 41
DE - Germania 34
FR - Francia 15
IN - India 14
SG - Singapore 13
IE - Irlanda 12
RU - Federazione Russa 12
TG - Togo 10
NG - Nigeria 8
BE - Belgio 7
EE - Estonia 7
ZA - Sudafrica 7
BG - Bulgaria 4
UA - Ucraina 4
CA - Canada 3
RO - Romania 3
CI - Costa d'Avorio 2
FI - Finlandia 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
PL - Polonia 2
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
MY - Malesia 1
NO - Norvegia 1
Totale 908
Città #
Fairfield 73
Southend 60
Ashburn 47
Chandler 42
Ann Arbor 39
Dong Ket 32
Houston 31
Woodbridge 28
Seattle 25
Cambridge 22
Wilmington 22
Princeton 14
Dublin 12
Bologna 11
Lomé 10
Dearborn 9
Nanjing 9
Singapore 9
Berlin 8
Abeokuta 7
Brussels 7
Westminster 7
Shenyang 6
Beijing 5
Boardman 5
Bremen 5
Padova 5
Hebei 4
Jiaxing 4
Jinan 4
Saint Petersburg 4
Agrate Brianza 3
Milan 3
Redmond 3
San Diego 3
Taizhou 3
Tianjin 3
Toronto 3
Abidjan 2
Amman 2
Changsha 2
Dallas 2
Falls Church 2
Florence 2
Hangzhou 2
Helsinki 2
London 2
Naples 2
New York 2
Phoenix 2
Venice 2
Andover 1
Bern 1
Brandenburg 1
Brescia 1
Chicago 1
Council Bluffs 1
Gallo 1
Guangzhou 1
Haikou 1
Hyderabad 1
Kuala Lumpur 1
Kuban 1
Lagos 1
Las Vegas 1
Leawood 1
Lviv 1
Madrid 1
Marigliano 1
Nanchang 1
Ningbo 1
Norwalk 1
Novokuznetsk 1
Nuremberg 1
Olalla 1
Panvel 1
Paris 1
Perugia 1
Pisa 1
Prato 1
Redwood City 1
Rochedale 1
Rome 1
San Francisco 1
Santa Clara 1
Sofia 1
São Paulo 1
Tel Aviv 1
Turin 1
Vienna 1
Warsaw 1
Zanjan 1
Totale 654
Nome #
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years 193
High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience 141
The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience 141
Long-term responders after Brentuximab vedotin: Single-center experience on relapsed and refractory hodgkin lymphoma and anaplastic large cell lymphoma patients 132
Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program 128
The treatment of primary mediastinal large B-cell lymphoma: A two decades monocentric experience with 98 patients 109
Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: Bridge to transplant 90
Totale 934
Categoria #
all - tutte 2.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020277 33 5 1 8 41 35 32 35 36 24 12 15
2020/2021128 26 6 13 1 4 2 1 5 16 5 6 43
2021/2022191 42 12 6 16 12 8 4 7 6 8 38 32
2022/2023211 15 37 16 32 14 22 7 16 29 7 7 9
2023/202452 3 12 3 4 4 4 5 2 0 8 2 5
2024/202512 12 0 0 0 0 0 0 0 0 0 0 0
Totale 934